Summit Therapeutics Inc.: Chief accounting officer Anand Bhaskar received 100,000 shares

What happened Anand Bhaskar, chief accounting officer, received a grant of 100,000 restricted stock units (reported as 100,000 shares) on Oct 8, 2026 at $0.00 per share, total reported value $0.

Key details

• Transaction date and price: Oct 8, 2026; grant price $0.00 per share; total reported value $0.
• Shares owned after the transaction: not specified in the provided filing.
• Footnote F1: RSUs granted under the issuer's Amended and Restated 2020 Stock Incentive Plan; the RSUs vest on Oct 8, 2029 subject to the reporting person continuing employment and will entitle the reporting person to one share of common stock for each RSU that vests.
• Footnote F2: Holdings include shares previously acquired through exempt transactions pursuant to the issuer's employee stock purchase plan.
• Filing date: Oct 14, 2026 (covers the Oct 8, 2026 transaction).

Why it may matter

• The transaction was an award of restricted stock units, not an open-market purchase or sale.
• The RSUs vest on Oct 8, 2029 subject to continued employment and convert 1:1 to common shares upon vesting.
• A filing does not show why the insider traded or why the company acted.